Dr. Jason Marc Deville, DO

Dr. Deville practices at Ngc Endoscopy Services, LLC - HOPD in Portland, Oregon.

Dr. Deville's NPI, 1255440459, was assigned on August 30, 2006. Dr. Deville graduated from Arizona College of Osteopathic Medicine - Glendale in 2003. Dr. Deville holds Washington license OP60007005.

Dr. Deville's primary practice is Ngc Endoscopy Services, LLC - HOPD, at 1130 Nw 22nd Ave, Portland, OR 97210.

Dr. Deville's primary practice is Ngc Endoscopy Services, LLC - HOPD in Portland, Oregon. Dr. Deville is also affiliated with Kaiser Permanente Sunnyside Medical Center. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. Deville to 1 more group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deville practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Deville's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Deville is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Deville's licenses on file in 3 states: Washington, Idaho and Oregon.

Dmand AI lists chronic kidney disease among the conditions Dr. Deville treats.

CMS data shows 40 Medicare services from Dr. Deville across 1 procedure code in 2024, for 35 Medicare patients. Medicare paid $2,441 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 35 Medicare patients who saw Dr. Deville in 2026. The largest group is under 65, with 15 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 46% are also on Medicaid. Their average risk score is 6.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deville's median patient age at 61, with 40% women.

In 2026, Dr. Deville wrote 1,770 Medicare Part D claims for 446 patients. 92% of them were for generic drugs. CMS names the drug for 1,595 of them, across 33 drugs with 11 or more claims each, at $127,144 in total drug cost. In 2023, CMS named 1,435 claims across 29 drugs.

Dr. Deville accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deville as offering telehealth.

Dmand AI links 2 papers to Dr. Deville in 2012.

CMS Open Payments shows 3 general payments to Dr. Deville from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 93% of the total. Genentech, Inc. paid the most, $88.

Dmand AI lists 1 award for Dr. Deville, most recently CMS Stage 1 2012 in 2011.

Dr. Deville graduated from Arizona College of Osteopathic Medicine - Glendale in 2003.

Dr. Deville is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.